Senores Pharma shares surge to post-listing high after 15% jump on Q1 results

Senores generates a majority of its revenue from regulated markets, which contributed 65% of total sales in the quarter. Revenue from this segment rose 69% YoY to ₹90 crore, and 40% QoQ.

Leave a Reply

Your email address will not be published. Required fields are marked *